Zoetis Inc. $ZTS Shares Acquired by Public Sector Pension Investment Board

Public Sector Pension Investment Board lifted its holdings in Zoetis Inc. (NYSE:ZTS) by 12.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,614 shares of the company’s stock after purchasing an additional 4,337 shares during the quarter. Public Sector Pension Investment Board’s holdings in Zoetis were worth $5,650,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Halbert Hargrove Global Advisors LLC grew its stake in shares of Zoetis by 496.6% during the third quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock worth $25,000 after acquiring an additional 144 shares during the last quarter. NewSquare Capital LLC raised its position in shares of Zoetis by 69.1% in the 2nd quarter. NewSquare Capital LLC now owns 208 shares of the company’s stock valued at $32,000 after purchasing an additional 85 shares during the last quarter. Financial Consulate Inc. acquired a new stake in Zoetis in the 3rd quarter worth approximately $39,000. SJS Investment Consulting Inc. grew its position in Zoetis by 1,606.3% during the 3rd quarter. SJS Investment Consulting Inc. now owns 273 shares of the company’s stock worth $40,000 after purchasing an additional 257 shares during the last quarter. Finally, TruNorth Capital Management LLC acquired a new position in Zoetis during the 3rd quarter valued at approximately $42,000. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Zoetis Stock Up 2.9%

Shares of ZTS opened at $129.17 on Thursday. The company has a market capitalization of $54.53 billion, a price-to-earnings ratio of 21.46, a PEG ratio of 1.92 and a beta of 0.96. Zoetis Inc. has a 52 week low of $115.25 and a 52 week high of $177.00. The stock’s 50-day moving average price is $125.01 and its 200-day moving average price is $135.02. The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71.

Zoetis (NYSE:ZTS) last announced its quarterly earnings results on Thursday, February 12th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.08. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The company had revenue of $2.39 billion during the quarter, compared to analysts’ expectations of $2.36 billion. During the same period last year, the business earned $1.40 earnings per share. Zoetis’s quarterly revenue was up 3.0% on a year-over-year basis. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. On average, sell-side analysts predict that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be given a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 1.6%. The ex-dividend date is Monday, April 20th. Zoetis’s dividend payout ratio (DPR) is currently 35.22%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ZTS. The Goldman Sachs Group upgraded shares of Zoetis to a “buy” rating in a research note on Monday, December 15th. UBS Group set a $136.00 price target on Zoetis in a research report on Thursday, January 29th. Weiss Ratings lowered Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, January 28th. Barclays initiated coverage on Zoetis in a research note on Monday, December 8th. They issued an “equal weight” rating and a $136.00 price objective for the company. Finally, KeyCorp initiated coverage on Zoetis in a research report on Thursday, November 20th. They issued a “sector weight” rating on the stock. Five analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Zoetis has an average rating of “Hold” and an average target price of $152.91.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.